COVID-19 Telehealth
Free telehealth for COVID-19 treatment with Paxlovid
Telehealth is a quick and easy way to see if Paxlovid, a COVID-19 treatment pill, is right for you.
Table of Contents
Who can take Paxlovid?
Contact
Paxlovid is for individuals age 12 and older who have tested positive for COVID-19, are at increased risk of severe disease, and have developed COVID-19 symptoms in the last 5 days, even mild ones (such as runny nose or cough).
Conditions that put you at higher risk for severe disease include being over age 50, a current or former smoker, cancer, diabetes, and obesity, among others.
If you feel that you are at risk contact us for a free consult.
On-site Medical Services
Support Team Phone
800-816-5803
Available 8 a.m. - 6 p.m. EST
Weekends 9 a.m. - 5 p.m. EST
Live On-line Help
Get a free video consultation
Available 8 a.m. - 6 p.m. EST
Weekends 9 a.m. - 5 p.m. EST
Free telehealth consultations are available for eligible individuals 18 or older who are currently living in New Hampshire and insurance is not required. If you’re eligible, you’ll be connected with a clinician for a phone or video consultation within 24 hours.
This service is not for medical emergencies or for individuals who are pregnant. If you are experiencing a medical emergency like having trouble breathing, please call 911.
Before getting started, make sure you have:
-
A list of medications or vitamins you are taking,
-
If you have kidney disease, a copy of your lab results from the last 3 months because the dose may need to be adjusted.
Clinicians are available every day from 8 a.m. to 6 p.m. EST.
This treatment is not a substitute for vaccination, which can prevent serious illness, hospitalization, and death. Learn more about getting vaccinated.
Learn more about COVID-19 treatments at CDC Treatment Options.
What is Paxlovid?
Paxlovid has been authorized for emergency use by FDA under an EUA, for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 88 lbs) with positive results of direct SARS CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death.
If Paxlovid is right for you, treatment should start as soon as possible after COVID-19 diagnosis and your first symptom in the last 5 days. Paxlovid is not for people who have a history of allergy to nirmatrelvir or ritonavir or other components of these drugs, and it is not for people taking certain other drugs. Paxlovid may cause side effects, some of which may be serious and unexpected. Learn more about Paxlovid on the manufacturer’s website, and review the patient and healthcare provider fact sheets for more information.
The emergency use of Paxlovid is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID19 pandemic under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization revoked sooner.
Symptoms
COVID-19 is a respiratory disease, caused by a novel (or new) coronavirus that emerged in late 2019. Reported illness ranges from mild symptoms to severe illness and death for confirmed COVID-19 cases.
Symptoms of infection may appear 2-14 days after exposure to the virus and may include:
-
Fever or chills
-
Cough
-
Shortness of breath or difficulty breathing
-
Fatigue
-
Muscle or body aches
-
Headache
-
New loss of sense of taste or smell
-
Sore throat
-
Congestion or runny nose
-
Nausea or vomiting
-
Diarrhea
-
In elderly, chronically ill, or debilitated individuals such as residents of a long-term care facility, symptoms of COVID-19 may be subtle such as alterations in mental status or in blood glucose control
-
However, it’s possible for people with COVID-19 to spread the virus to others up to 48 hours before they have symptoms. Visit the CDC's resource on symptoms for more information.
If you develop symptoms of COVID-19, even if they are mild, please contact your healthcare provider and a test site near you to schedule a test.
On-site Medical Services, LLC. is a privately held company. The COVID-19 vaccination program is financed under a contract with the State of New Hampshire, Department of Health and Human Services, with funds provided in part by the State of New Hampshire and/or such other funding sources as were available or required, e.g., the United States Department of Health and Human Services.